Harrow.io Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
6
- Latest Deal Type
-
Out of Business
Harrow.io General Information
Description
Developer of a task-runner platform intended for people who build and manage software. The company's platform is designed to sit in the place of a traditional continuous integration and continuous delivery build system and automate any script in any language, make all activities transparent to the team, get full documentation and more, enabling clients to deploy, test, automate and monitor collaboratively.
Contact Information
Website
www.harrow.ioCorporate Office
- Hamburg
- Germany
Corporate Office
- Hamburg
- Germany
Harrow.io Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Feb-2019 | Completed | Out of Business | |||
| 2. Seed Round | 27-Apr-2016 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 14-Apr-2016 | Completed | Generating Revenue |
Harrow.io Comparisons
Industry
Financing
Details
Harrow.io Competitors (1)
One of Harrow.io’s competitors is Octavia, a Formerly Accelerator/Incubator backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Octavia | Formerly Accelerator/Incubator backed | London, United Kingdom |
Harrow.io Patents
Harrow.io Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020092402-A1 | Pharmaceutical compositions of tiopronin and methods for preparing thereof | Inactive | 30-Oct-2018 | ||
| WO-2020069005-A1 | Pharmaceutical compositions for prevention or treatment of cytokine release syndrome | Inactive | 28-Sep-2018 | ||
| US-10695351-B2 | Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof | Active | 30-Jul-2018 | ||
| US-20200030334-A1 | Pharmaceutical formulations for the treatment of dry eye and methods for fabricating and using thereof | Active | 30-Jul-2018 | ||
| WO-2019236857-A1 | Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof | Inactive | 08-Jun-2018 | A61K31/505 |
Harrow.io Signals
Harrow.io FAQs
-
When was Harrow.io founded?
Harrow.io was founded in 2014.
-
Where is Harrow.io headquartered?
Harrow.io is headquartered in Hamburg, Germany.
-
What is the size of Harrow.io?
Harrow.io has 6 total employees.
-
What industry is Harrow.io in?
Harrow.io’s primary industry is Software Development Applications.
-
Is Harrow.io a private or public company?
Harrow.io is a Private company.
-
What is Harrow.io’s current revenue?
The current revenue for Harrow.io is .
-
Who are Harrow.io’s competitors?
Octavia is a competitor of Harrow.io.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process